CIK 0001527599 · Non-accelerated filer<br>Smaller reporting company
SYNLOGIC, INC.
Sign in to watch- Ticker
- SYBX
- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 261824804
- Phone
- 617-659-2802
- Business address
- PO BOX 30, WINCHESTER, MA, 01890
- Former names
- Mirna Therapeutics, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 94 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-11-10 | Brennan Aoife President and CEO | Returned to the company · Stock Option (right to buy) | −28,943 | 0 | ||
| 2023-11-10 | Brennan Aoife President and CEO | Returned to the company · Stock Option (right to buy) | −42,999 | 0 | ||
| 2023-11-10 | Brennan Aoife President and CEO | Returned to the company · Stock Option (right to buy) | −8,666 | 0 | ||
| 2023-11-10 | Brennan Aoife President and CEO | Grant or award · Stock Option (right to buy) | +5,591 | 5,591 | ||
| 2023-11-10 | Brennan Aoife President and CEO | Grant or award · Stock Option (right to buy) | +3,733 | 3,733 | ||
| 2023-11-10 | Brennan Aoife President and CEO | Grant or award · Stock Option (right to buy) | +3,600 | 3,600 | ||
| 2023-11-10 | Brennan Aoife President and CEO | Grant or award · Stock Option (right to buy) | +9,999 | 9,999 | ||
| 2023-11-10 | Brennan Aoife President and CEO | Grant or award · Stock Option (right to buy) | +12,332 | 12,332 | ||
| 2023-11-10 | Brennan Aoife President and CEO | Grant or award · Stock Option (right to buy) | +12,352 | 12,352 | ||
| 2023-11-10 | Brennan Aoife President and CEO | Grant or award · Stock Option (right to buy) | +18,999 | 18,999 | ||
| 2023-11-10 | Brennan Aoife President and CEO | Grant or award · Stock Option (right to buy) | +28,943 | 28,943 | ||
| 2023-11-10 | Brennan Aoife President and CEO | Grant or award · Stock Option (right to buy) | +42,999 | 42,999 | ||
| 2023-11-10 | Brennan Aoife President and CEO | Grant or award · Stock Option (right to buy) | +8,666 | 8,666 | ||
| 2023-11-10 | JENSEN MICHAEL VANGSTED Chief Financial Officer | Returned to the company · Stock Option (right to buy) | −15,332 | 0 | ||
| 2023-11-10 | JENSEN MICHAEL VANGSTED Chief Financial Officer | Returned to the company · Stock Option (right to buy) | −13,332 | 0 | ||
| 2023-11-10 | JENSEN MICHAEL VANGSTED Chief Financial Officer | Returned to the company · Stock Option (right to buy) | −6,666 | 0 | ||
| 2023-11-10 | JENSEN MICHAEL VANGSTED Chief Financial Officer | Grant or award · Stock Option (right to buy) | +15,332 | 15,332 | ||
| 2023-11-10 | JENSEN MICHAEL VANGSTED Chief Financial Officer | Grant or award · Stock Option (right to buy) | +13,332 | 13,332 | ||
| 2023-11-10 | JENSEN MICHAEL VANGSTED Chief Financial Officer | Grant or award · Stock Option (right to buy) | +6,666 | 6,666 | ||
| 2023-11-10 | Awad Antoine Chief Operating Officer | Returned to the company · Stock Option (right to buy) | −3,666 | 0 |
Page 2 of 8 · 152 trades